Lucid Diagnostics Inc. Balance Sheet
LUCD|4 years of annual SEC 10-K data (FY2021-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$31M
FY2024
Cash
$22M
Cash and equivalents
Total Debt
N/A
FY2024
Shareholder Equity
-$2M
FY2024
Lucid Diagnostics Inc. had $31M in total assets with negative shareholders' equity of $2M as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash & Equivalents | $22.4M | $18.9M | $22.5M | - |
| Accounts Receivable | $45.0K | $45.0K | $17.0K | $200.0K |
| Inventory | $341.0K | $278.0K | - | - |
| Current Assets | $25.1M | $22.1M | $24.4M | $57.3M |
| PP&E (Net) | $1.1M | $1.3M | $1.6M | $971.0K |
| Total Assets | $30.7M | $27.3M | $32.5M | $59.0M |
| Current Liabilities | $23.5M | $29.4M | $8.4M | - |
| Shareholders' Equity | -$2.3M | $23.0M | $54.7M | -$13.5M |